نتایج جستجو برای: chronic myeloid leukemia

تعداد نتایج: 744967  

Journal: :journal of paramedical sciences 0
sadegh babashah department of genetics, faculty of biological sciences, tarbiat modares university, tehran mostafa rezaei-tavirani proteomics research center, faculty of paramedical sciences, shahid beheshti university of medical sciences, tehran mona zamanian-azodi proteomics research center, faculty of paramedical sciences, shahid beheshti university of medical sciences, tehran najmaldin saki research center of thalassemia and hemoglobinopathy, ahvaz jundishapur university of medical sciences, ahvaz

chronic myeloid leukemia (cml) is a myeloproliferative disease of the hematopoietic stem cells, characterized by the presence of the philadelphia (ph) chromosome. although imatinib inhibits the bcr-abl kinase activity, clinical experiences confirm that imatinib may not target cml stem cells in vivo. the identification of signaling pathways responsible for the self-renewal properties of leukemic...

ژورنال: پیاورد سلامت 2017
درخشانفر, الهه, رفیعی مهر, حسن, شباب, نوشین, علیزاده, شعبان, قاسمی, علی, نادعلی, فاطمه, کریمی, مسعود,

Background and Aim: Chronic myeloid leukemia (CML) is a myeloprolifrative neoplasm that is characterized by an expansion of myeloid, erythroid cells and platelets in peripheral blood and myeloid hyperplasia in bone marrow. Secreted frizzled-related protein family is a negative regulator of the Wnt signaling pathway that suppresses this signaling pathway in healthy individuals. Aberrant regulati...

اصلانی, الهه, رنجبر, منیره, نقش, نوشین,

Background and Objective: Chronic myeloid leukemia (CML) is a malignant clonal disorder of hematopoietic stem cells which results in increase of myeloid and erythroid cells and platelets in the peripheral blood and hyperplasia in bone marrow. This research evaluated the cytotoxic effect of aqueous, methanolic and ethanolic extracts of M. spicata leaves on K562 cell line as a model of chronic my...

Journal: :Mayo Clinic proceedings 2006
Ayalew Tefferi Michelle A Elliott Animesh Pardanani

Myeloid disorders constitute a subgroup of hematological malignancies that is separate from lymphoid disorders. The World Health Organization system for classification of tumors of the hematopoietic system divides myeloid disorders into acute myeloid leukemia and chronic myeloid disorders based on the presence or absence, respectively, of acute myeloid leukemia--defining morphological and cytog...

2009
Anne Tyybäkinoja

................................................................................................................................ 9 INTRODUCTION ..................................................................................................................... 10 REVIEW OF THE LITERATURE ......................................................................................... 11 1. Cancer and ...

Journal: :مجله بین المللی علوم آزمایشگاهی 0
kaveh tari arezou rahimi amir atashi saeid abroun mohammad shahjahani ali jalili

hematopoietic stem/progenitor cells (hspcs) which give rise to different blood cell types are present within the bone marrow microenvironment, especially in flat bones such as skull, vertebrae, pelvis and chest. interacting factors such as stromal derived factor-1/cxcr4, very late antigen-4/vascular cell adhesion molecule-1, lymphocyte function-associated antigen-1/ intercellular adhesion molec...

Journal: : 2023

Viral infections especially herpes virus and varicella zoster are common complications in patients with hematologic malignancies. The spectrum of infectious during after dasatinib therapy not known. I report here recurrent labialis two chronic myeloid leukemia cases treated dasatinib.

Journal: :Emerging Cancer Therapeutics 2011

Journal: :Haematologica 2010
Fabrizio Vianello Federica Villanova Veronica Tisato Stefania Lymperi Ka-Kei Ho Ana R Gomes David Marin Dominique Bonnet Jane Apperley Eric W-F Lam Francesco Dazzi

BACKGROUND Residual chronic myeloid leukemia disease following imatinib treatment has been attributed to the presence of quiescent leukemic stem cells intrinsically resistant to imatinib. Mesenchymal stromal cells in the bone marrow may favor the persistence and progression of leukemia by preserving the proliferation and self-renewal capacities of the malignant progenitor cells. DESIGN AND ME...

Journal: :Haematologica 1999
M Carrasco A Remacha A Sureda P Sardà R Martino J Sierra

1. Caballero MD, Gonzalez M, Canizo MC, Orfao A, Nieto MJ, San-Miguel JF. Concomitant chronic lymphocytic leukemia (CLL) and acute myeloid leukemia. Complete remission of CLL achieved with high-dose cytosine arabinoside. Leukemia 1992; 6:856-8. 2. Conlan MG, Mosher DF. Concomitant chronic lymphocytic leukemia, acute myeloid leukemia, and thrombosis with protein C deficiency. Case report and rev...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید